The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090

By AHRMM

AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).

Related Resources

Webcast
Dr. Randy Bradley discusses the attributes leaders must have in order to be effective when managing a multi-generational workforce.
Webcast
Karen Conway, Vice President, Healthcare Value at GHX and Mike Schiller, Senior Director of Supply Chain at AHRMM discuss the value of UDI beyond r
Podcasts
Dr. Cherf, Chief Medical Officer at Lumere, and Dr.
Webcast
AHRMM presents a four-part series on successful collaboration with suppliers.
Book
This book was written to enhance the strategic contributions of the healthcare supply chain in a way that is most meaningful to hospitals’ an
On-Demand Educational Webinars
Cybersecurity impacts all industry verticals including health care. Health care organizations need to address security in standard technology and…